CL vs KVUE
Colgate-Palmolive and Kenvue, both Consumer Defensive
Colgate-Palmolive is the larger company at $72B against $35B. On trailing earnings KVUE is the cheaper of the two at a P/E of 20.3 against 34.9, a gap that is only a bargain if the two are growing at similar rates. Over the past year CL returned +10% against +1.2% for KVUE. The RyuScore puts CL ahead, 74 against 54 out of 100.
| Figure | CL | KVUE |
|---|---|---|
| Last close | $88.27 | $17.67 |
| Market cap | $72B | $35B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 34.9 | 20.3 |
| Dividend yield | 2.4% | 4.7% |
| 1-year return | +10% | +1.2% |
| 5-year return | +28% | n/a |
| RyuScoresector-relative, 1–10 | 74/100 | 54/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Colgate-Palmolive
Revenue of $5.4B in Q2 2026, net income $693M. Its largest reported line is Latin America, 33% of the disclosed total.
Kenvue
Revenue of $4.0B in Q2 2026, net income $456M. Its largest reported line is Self Care, 40% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.